FI895084A0 - 3b, 17b-hydroxisubstituerade steroider och steroida naerbeslaektade foereningar. - Google Patents

3b, 17b-hydroxisubstituerade steroider och steroida naerbeslaektade foereningar.

Info

Publication number
FI895084A0
FI895084A0 FI895084A FI895084A FI895084A0 FI 895084 A0 FI895084 A0 FI 895084A0 FI 895084 A FI895084 A FI 895084A FI 895084 A FI895084 A FI 895084A FI 895084 A0 FI895084 A0 FI 895084A0
Authority
FI
Finland
Prior art keywords
compounds
steroider
naerbeslaektade
steroida
foereningar
Prior art date
Application number
FI895084A
Other languages
English (en)
Inventor
John O'neal Johnston
Gene Warwick Holbert
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI895084A0 publication Critical patent/FI895084A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters
FI895084A 1988-10-27 1989-10-26 3b, 17b-hydroxisubstituerade steroider och steroida naerbeslaektade foereningar. FI895084A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/263,091 US4882322A (en) 1988-10-27 1988-10-27 3β,17β-hydroxy-substituted steroids and related steroidal compounds

Publications (1)

Publication Number Publication Date
FI895084A0 true FI895084A0 (fi) 1989-10-26

Family

ID=23000340

Family Applications (1)

Application Number Title Priority Date Filing Date
FI895084A FI895084A0 (fi) 1988-10-27 1989-10-26 3b, 17b-hydroxisubstituerade steroider och steroida naerbeslaektade foereningar.

Country Status (18)

Country Link
US (1) US4882322A (fi)
EP (1) EP0366144B1 (fi)
JP (1) JP2750621B2 (fi)
KR (1) KR900006360A (fi)
CN (1) CN1042363A (fi)
AT (1) ATE111478T1 (fi)
AU (1) AU619608B2 (fi)
CA (1) CA2001264C (fi)
DE (1) DE68918219T2 (fi)
DK (1) DK533189A (fi)
ES (1) ES2063801T3 (fi)
FI (1) FI895084A0 (fi)
HU (1) HU204065B (fi)
IL (1) IL92103A0 (fi)
NO (1) NO173097C (fi)
NZ (1) NZ231107A (fi)
PT (1) PT92113B (fi)
ZA (1) ZA898025B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166201A (en) * 1990-11-30 1992-11-24 Merrell Dow Pharmaceuticals Inc. 2β,19-ethylene bridged steroids as aromatase inhibitors
EP1079859B1 (en) 1998-05-22 2010-07-14 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
EP1689768A2 (en) * 2003-11-24 2006-08-16 Merck & Co., Inc. Estrogen receptor modulators
US20070099880A1 (en) * 2003-11-24 2007-05-03 Blizzard Timothy A Estrogen receptor modulators
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
NZ594310A (en) 2009-02-20 2014-02-28 To Bbb Holding B V Glutathione-based drug delivery system
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
CN103555806B (zh) * 2013-11-16 2015-05-13 江南大学 一种高效利用亚麻刺盘孢霉合成7α-羟基-雄甾烯酮的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
GB8531747D0 (en) * 1985-12-24 1986-02-05 Erba Farmitalia 10beta-alkynylestrene derivatives

Also Published As

Publication number Publication date
IL92103A0 (en) 1990-07-12
CN1042363A (zh) 1990-05-23
PT92113A (pt) 1990-04-30
CA2001264C (en) 2001-05-01
JPH02174793A (ja) 1990-07-06
NO894276D0 (no) 1989-10-26
ATE111478T1 (de) 1994-09-15
ES2063801T3 (es) 1995-01-16
ZA898025B (en) 1990-07-25
AU4367989A (en) 1990-05-31
PT92113B (pt) 1995-06-30
CA2001264A1 (en) 1990-04-27
HU895457D0 (en) 1990-01-28
NO173097C (no) 1993-10-27
EP0366144A1 (en) 1990-05-02
DK533189A (da) 1990-04-28
DE68918219T2 (de) 1995-02-02
US4882322A (en) 1989-11-21
DE68918219D1 (de) 1994-10-20
AU619608B2 (en) 1992-01-30
NO894276L (no) 1990-04-30
JP2750621B2 (ja) 1998-05-13
HUT52113A (en) 1990-06-28
EP0366144B1 (en) 1994-09-14
KR900006360A (ko) 1990-05-08
HU204065B (en) 1991-11-28
NO173097B (no) 1993-07-19
DK533189D0 (da) 1989-10-26
NZ231107A (en) 1992-03-26

Similar Documents

Publication Publication Date Title
GR3003350T3 (en) Process for neutralizing unpleasant odours of animal excreta
DE69132048D1 (de) Verwendung von Steroiden zur Inhibierung von Angiogenesis
FI895084A0 (fi) 3b, 17b-hydroxisubstituerade steroider och steroida naerbeslaektade foereningar.
GR1000597B (el) Παραγοντας αναστολης αναπτυξης και χρηση του.
SI1169337T1 (en) Steroid nitrates for the treatment of oxidative injury and endothelial dysfunction
IL104105A (en) 19-nor steroids having a thiocarbon chain in position 11-beta, their preparation and pharmaceutical compositions containing them
ES2078890T3 (es) Amino esteroides en c20 a c26.
PT93263A (pt) Processo para a preparacao de 19-nor esteroides contendo na posicao 11-beta umacadeia carbonada possuindo uma funcao amida ou carbamato
ES533261A0 (es) Procedimiento para la preparacion de 1-alquil-androsta-1,4-dien-3,17-dionas
PT77408A (de) Neue 6alpha-methylkortikoide ihre herstellung und verwendung
DE69115745D1 (de) Verwendung von Steroidderivaten zur Behandlung der Endometriose
IL90727A0 (en) 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors
ES553608A0 (es) Procedimiento de preparacion de 21-hidroxi-20-ceto-delta16-esteroides
DE69111108T2 (de) Haloethyl substituierte enzymhemmende Steroiden.
WO1990015067A3 (fr) NOUVEAUX PROCEDES D'OBTENTION DE 6-METHYL 19-NOR STEROIDES ET LEUR CONVERSION EN 19-NOR PREGNADIENES 17α-SUBSTITUES
SE8600828L (sv) Steroidderivat i androstanserien
FI943835A (fi) Välituotteet käytettäväksi steroidi-5-alfa-reduktaasin inhibiittoreiden valmistamiseksi

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.